[23] Future studies of protein C genetic polymorphisms and other coagulation factors might lead to identification of patients who are at high risk of an adverse event when they develop severe sepsis.

In patients with protein C and protein S deficiency, when warfarin therapy is started there is a more rapid fall in concentration of protein C (antigen and activity) than the other vitamin K ...

The team used statistical analysis to examine how these numbers interacted with coagulation markers ... a marker for clotting, and C-reactive protein, a marker for inflammation.